Evaluation of Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography in Patients With Sarcoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMayo Clinic
About this trial
This study evaluates the effectiveness of intraoperative indocyanine green dye and fluoroscopic technology in confirming negative margins after tumor removal.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with biopsy-proven bone or soft tissue sarcoma undergoing resection
Disqualifiers
Chronic kidney disease
Anaphylaxis to dyes
Trial population
Patients with biopsy-proven bone or soft tissue sarcoma undergoing resection recruited through Mayo Clinic
Trial design
Design model
Cohort
Time perspective
Cross-sectional
Treatments tested in this trial
Non-Interventional Study
Other interventionNon-interventional study
Treatment groups
75 Participants
are divided into 1 treatment groupGroup A: Observational1 intervention
Trial outcomes
Primary outcomes
1
Accuracy of intraoperative ICG fluorescence compared to final pathology results
Intraoperative ICG fluorescence and deduced margins will be analyzed and compared the accuracy to final pathology margins. Negative predictive value will be calculated.
Time frame
BaselineSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov